Acknowledging a successful career, a significant contribution to drug discovery and the ELRIG community, as well as a recent OBE, Steve Rees, VP Discovery Biology, R&D, AstraZeneca, discusses pivotal moments in his career, the work he coordinated around the Cambridge Covid-19 Test Centre, and his eagerness to re-connect with friends and colleagues… Read More
The Covid-19 pandemic has forced the drug discovery industry to re-imagine how it operates, as well as the roles within it. Rob Howes, Director of AstraZeneca's Cambridge Covid-19 Testing Centre, believes ELRIG’s Drug Discovery 2021 will be an opportunity for the industry to re-connect as we return to in-person events and scientists return… Read More
Registration is now open for Pittcon 2022, which will take place in Atlanta, Georgia, USA, March 5 – 9, 2022. Pittcon is a transnational exposition and comprehensive technical conference, a venue for examining the latest advances in research and scientific instrumentation, and a platform for continuing education… Read More
BenevolentAI has idenitifed a preclinical candidate for a novel ulcerative colitis target. It is in IND/CTA-enabling studies and the company plans to advance it to move the programme into the clinic in early 2023. Scientists deployed BenevolentAI’s target ID tools and machine learning models to identify and experimentally validate a novel biological… Read More
Collaborative Drug Discovery (CDD) has released a free, full featured, standalone software tool: CDD Visualization. It is a browser-based application that allows scientists to visualise data and generate publication-ready graphs and plots. If researchers are willing to share their data with the community, CDD hosts it for free. CDD… Read More
Digital therapeutics (DTx) uses digital technology to remotely prevent, treat, or manage a wide range of conditions through data-driven interventions; GlobalData says several opportunities exist in the digital therapeutics market for neurological diseases in Japan. Shionogi & Co, a partner of Akili Interactive, a prescription digital medicine company of PureTech Health, has… Read More
Sara Imarisio, Head of Strategic Initiatives at Alzheimer’s Research UK, reveals what dementia research could deliver and how Alzheimer’s research can help us re-imagine a future in which lives are saved. Alzheimer’s and other forms of dementia have been impacted by Covid-19. With many labs forced to close during lockdown, and social… Read More
Two Mount Sinai cancer researchers will receive $4 million from the National Institutes of Health (NIH) Common Fund, which supports research by junior scientists around the United States. This will fund radiation oncology and CAR T cell cancer therapy research. Deborah Marshall, Assistant Professor of Radiation Oncology at The Tisch… Read More
Chun-wa Chung discusses why the world of drug discovery excites her and offers advice for early career professionals, emphasising her admiration for how the industry has managed to re-imagine its potential and anticipating the opportunity to re-connect and share these learnings. Career journey Chung’s career within drug discovery and with GlaxoSmithKline (GSK) spans… Read More
Many small molecule inhibitors have been approved as cancer therapeutics, but they can confer mutation-based drug resistance and many potential cancer targets remain ‘undruggable’. One emerging cancer therapeutic strategy that shows promise for drug development is the use of targeted protein degradation (TPD). This approach has many advantages,… Read More
Learn more about Flow Robotics’ Flowbot One at booth B4 at ELRIG UK’s Drug Discovery 2021 conference in Liverpool from October 19-20. Flow Robotics shares that Drug Discovery 2021 will be its pipetting robot Flowbot One’s British conference debut. It has been developed to reduce hands-on time in laboratories and allows… Read More
Prachi Bogetto leads the Translational Research business at Leica Microsystems, and discusses the importance of imaging innovations when it comes to the fight against cancer. Drug discovery is increasingly informed by scientific insight derived using artificial intelligence (AI). In microscopy, in particular, computational solutions powered by AI and machine learning… Read More
Valo Health is a technology company built to transform drug discovery and development using human-centric data and artificial intelligence-powered compute. VP of Integrated Research, Guido Lanza talks to DDW in its Drug Discovery 2021 supplement about how Valo Health is re-inventing and innovating to overcome the fragmented, outdated drug discovery and development… Read More
News round-up by DDW’s Megan Thomas for 11-15 October For this week’s drug discovery round up, DDW’s Megan Thomas has selected five stories that showcase how organisations and collaboration within the drug discovery industry can provide researchers and drug developers with the tools they need to move forward with… Read More
Medidata’s Rave Imaging, the company’s cloud-based, secure clinical trial imaging management platform, has now supported more than 1,000 imaging studies. Rave Imaging processes more than 100 million images annually. The technology provides real-time visibility into imaging-related trial activities to enhance study efficiency. Paul McCracken, VP and… Read More
Clinical researchers can now benefit from a new range of fully compliant and sustainable refrigerators designed specifically for the cold storage of blood and blood-related products and samples. The Thermo Scientific TSB Series of blood bank refrigerators are built to comply with the Class IIa regulation 93/42/CE. Factory presets… Read More
